Fusen Pharmaceutical Company Limited (1652.HK)
HKD 0.81
(-2.41%)
HKD 0.81
(-2.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -73.33 Million | 110.49 Million | 47.76 Million | 153.2 Million | 20.39 Million | 62.81 Million |
| Net Income | -29.44 Million | -30.99 Million | 23.79 Million | 78.4 Million | 63.81 Million | 123.81 Million |
| Depreciation & Amortization | 35.79 Million | 34.16 Million | 23.78 Million | 22.45 Million | 21.23 Million | 16.8 Million |
| Deferred income taxes | - | - | - | -14.54 Million | -26.25 Million | - |
| Stock-based compensation | 1.45 Million | 1.15 Million | - | 17.63 Million | 4.42 Million | - |
| Change in working capital | -140.21 Million | 38.4 Million | -30.59 Million | 44.24 Million | -47.66 Million | -68.93 Million |
| Other non-cash items | 7.75 Million | 67.76 Million | 30.78 Million | 5.01 Million | 4.83 Million | -8.87 Million |
| Investing Cash Flow | -108.31 Million | -13.13 Million | -282.97 Million | -68.19 Million | -261.25 Million | -90.72 Million |
| Investments in PPE | -88.51 Million | -23.86 Million | -110.13 Million | -58.64 Million | -200.27 Million | -104.35 Million |
| Acquisitions | - | - | -153 Million | - | -62.97 Million | - |
| Investment purchases | -11.32 Million | - | -654 Thousand | -76.45 Million | - | - |
| Sales/Maturities of investments | - | 715 Thousand | 13.53 Million | 63.93 Million | - | - |
| Other Investing Activities | -16.95 Million | 10.01 Million | -32.72 Million | 2.97 Million | 1.99 Million | 13.63 Million |
| Financing Cash Flow | 88.5 Million | -51.76 Million | 20.52 Million | -116.33 Million | 5.44 Million | 100.84 Million |
| Debt repayment | -119.73 Million | -306.52 Million | -245.56 Million | -220 Million | -100 Million | -396.56 Million |
| Dividends payments | - | -6.95 Million | -8.3 Million | -3.14 Million | -5.31 Million | -1.06 Million |
| Common Stock Repurchased | -15.98 Million | -10.07 Million | -7.39 Million | -94.79 Million | - | - |
| Common Stock Issuance | - | - | - | 201.93 Million | - | 335.01 Million |
| Other Financing Activities | -12.58 Million | 271.79 Million | 281.79 Million | -330 Thousand | 110.75 Million | 163.45 Million |
| Accounts receivables | 49.86 Million | -90.56 Million | 25.97 Million | -12.31 Million | -48.64 Million | 10.09 Million |
| Accounts payables | - | 90.56 Million | -25.97 Million | 12.31 Million | 48.64 Million | - |
| Inventory | -51.06 Million | 11.19 Million | -16.43 Million | -17.01 Million | 52.38 Million | -40.28 Million |
| Other working capital | -79.28 Million | 27.21 Million | -14.16 Million | 61.25 Million | -100.04 Million | -28.65 Million |
| Cash at beginning of period | 128.1 Million | 81.06 Million | 297.03 Million | 331.04 Million | 561.1 Million | 474.62 Million |
| Cash at end of period | 34.84 Million | 128.1 Million | 81.06 Million | 297.03 Million | 331.04 Million | 561.1 Million |
| Capital Expenditure | -88.51 Million | -23.86 Million | -110.13 Million | -58.64 Million | -200.27 Million | -104.35 Million |
| Effect of forex changes on cash | -108 Thousand | 1.45 Million | -1.29 Million | -2.68 Million | 5.35 Million | 13.54 Million |
| Net cash flow / Change in cash | -93.25 Million | 47.04 Million | -215.97 Million | -34 Million | -230.06 Million | 86.48 Million |
| Free Cash Flow | -161.84 Million | 86.62 Million | -62.36 Million | 94.56 Million | -179.88 Million | -41.53 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.47 Million | -18.47 Million | -29.44 Million | -26.36 Million | -26.36 Million | 8.22 Million |
| Depreciation & Amortization | 10.41 Million | 10.41 Million | 35.79 Million | 9.47 Million | 9.47 Million | 8.42 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 1.45 Million | 726.5 Thousand | 726.5 Thousand | - |
| Change in working capital | - | - | -140.21 Million | -40.24 Million | -40.24 Million | - |
| Other non-cash items | 4.92 Million | 4.92 Million | 7.75 Million | 42.91 Million | 42.91 Million | -39.82 Million |
| Investing Cash Flow | -22.17 Million | -22.17 Million | -108.31 Million | -16.95 Million | -16.95 Million | -37.2 Million |
| Investments in PPE | -22.99 Million | -22.99 Million | -88.51 Million | -12.1 Million | -12.1 Million | -21.01 Million |
| Acquisitions | - | - | - | - | - | 1.83 Million |
| Investment purchases | - | - | -11.32 Million | - | - | -10.88 Million |
| Sales/Maturities of investments | - | - | - | - | - | 9.04 Million |
| Other Investing Activities | 823 Thousand | 823 Thousand | -16.95 Million | -4.84 Million | -4.84 Million | -16.19 Million |
| Financing Cash Flow | 9.35 Million | 9.35 Million | 88.5 Million | 8.84 Million | 8.84 Million | 35.4 Million |
| Debt repayment | - | - | -119.73 Million | - | - | -69.86 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -3.23 Million | -3.23 Million | -15.98 Million | -3.13 Million | -3.13 Million | -4.85 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 12.58 Million | 12.58 Million | -12.58 Million | 11.98 Million | 11.98 Million | 40.25 Million |
| Accounts receivables | - | - | 49.86 Million | 24.93 Million | 24.93 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -51.06 Million | -25.53 Million | -25.53 Million | - |
| Other working capital | - | - | -79.28 Million | -39.64 Million | -39.64 Million | - |
| Cash at beginning of period | - | - | 128.1 Million | - | - | 166.45 Million |
| Cash at end of period | -16.01 Million | -16.01 Million | 34.84 Million | -21.72 Million | -21.72 Million | 84.47 Million |
| Capital Expenditure | -22.99 Million | -22.99 Million | -88.51 Million | -12.1 Million | -12.1 Million | -21.01 Million |
| Effect of forex changes on cash | -60 Thousand | -60 Thousand | -108 Thousand | -129 Thousand | -129 Thousand | 75 Thousand |
| Net cash flow / Change in cash | -16.01 Million | -16.01 Million | -93.25 Million | -21.72 Million | -21.72 Million | -81.98 Million |
| Free Cash Flow | -26.12 Million | -26.12 Million | -161.84 Million | -25.59 Million | -25.59 Million | -44.19 Million |
EPSOMPRO
CODAF
TINNATFL
BTPN
BHB
3696